Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.
Saved in:
| Title: | Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma. |
|---|---|
| Authors: | Ewen T; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Husain A; Novo Path and Cellular Pathology., Stefanos N; Pathology, Addenbrookes Hospital, Cambridge University NHS Trust, Cambridge, UK., Barrett P; Pathology, University Hospitals of North Durham, Durham, UK., Jones C; Novo Path and Cellular Pathology., Ness T; Novo Path and Cellular Pathology., Long A; Novo Path and Cellular Pathology., Horswell S; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Francis Crick Institute, London, UK., Bosomworth H; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Lowenstein J; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK., Richardson G; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK., Swan D; AMLo Biosciences, Newcastle upon Tyne, UK.; Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK., McConnell A; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK., Rose A; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Andrew T; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Reynolds N; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Malvehy J; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain., Carrera C; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain., Alos L; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain., Mailer S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Helm T; Division of Dermatology, Buffalo Medical Group, Williamsville, NY, USA.; Department of Dermatology, Penn State Hershey, Hershey, Pennsylvania, USA., Ding L; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Bogner P; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Podlipnik S; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain., Puig S; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain., McArthur GA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Paragh G; Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Labus M; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK., Sloan P; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Novo Path and Cellular Pathology.; AMLo Biosciences, Newcastle upon Tyne, UK., Armstrong JL; AMLo Biosciences, Newcastle upon Tyne, UK.; Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK., Lovat PE; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK. |
| Source: | The British journal of dermatology [Br J Dermatol] 2024 Mar 15; Vol. 190 (4), pp. 549-558. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38006317 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ewen+T%22">Ewen T</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Husain+A%22">Husain A</searchLink>; Novo Path and Cellular Pathology.<br /><searchLink fieldCode="AU" term="%22Stefanos+N%22">Stefanos N</searchLink>; Pathology, Addenbrookes Hospital, Cambridge University NHS Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Barrett+P%22">Barrett P</searchLink>; Pathology, University Hospitals of North Durham, Durham, UK.<br /><searchLink fieldCode="AU" term="%22Jones+C%22">Jones C</searchLink>; Novo Path and Cellular Pathology.<br /><searchLink fieldCode="AU" term="%22Ness+T%22">Ness T</searchLink>; Novo Path and Cellular Pathology.<br /><searchLink fieldCode="AU" term="%22Long+A%22">Long A</searchLink>; Novo Path and Cellular Pathology.<br /><searchLink fieldCode="AU" term="%22Horswell+S%22">Horswell S</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Bosomworth+H%22">Bosomworth H</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Lowenstein+J%22">Lowenstein J</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Richardson+G%22">Richardson G</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Swan+D%22">Swan D</searchLink>; AMLo Biosciences, Newcastle upon Tyne, UK.; Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK.<br /><searchLink fieldCode="AU" term="%22McConnell+A%22">McConnell A</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Rose+A%22">Rose A</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Andrew+T%22">Andrew T</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Reynolds+N%22">Reynolds N</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Malvehy+J%22">Malvehy J</searchLink>; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Carrera+C%22">Carrera C</searchLink>; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Alos+L%22">Alos L</searchLink>; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mailer+S%22">Mailer S</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Helm+T%22">Helm T</searchLink>; Division of Dermatology, Buffalo Medical Group, Williamsville, NY, USA.; Department of Dermatology, Penn State Hershey, Hershey, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Ding+L%22">Ding L</searchLink>; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bogner+P%22">Bogner P</searchLink>; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Podlipnik+S%22">Podlipnik S</searchLink>; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Puig+S%22">Puig S</searchLink>; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22McArthur+GA%22">McArthur GA</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Paragh+G%22">Paragh G</searchLink>; Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Labus+M%22">Labus M</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Sloan+P%22">Sloan P</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Novo Path and Cellular Pathology.; AMLo Biosciences, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Armstrong+JL%22">Armstrong JL</searchLink>; AMLo Biosciences, Newcastle upon Tyne, UK.; Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK.<br /><searchLink fieldCode="AU" term="%22Lovat+PE%22">Lovat PE</searchLink>; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220004041%22">The British journal of dermatology</searchLink> [Br J Dermatol] 2024 Mar 15; Vol. 190 (4), pp. 549-558. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0004041 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2133 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070963%22">00070963 </searchLink><i>NLM ISO Abbreviation: </i>Br J Dermatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38006317 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/bjd/ljad459 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 549 Titles: – TitleFull: Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ewen T – PersonEntity: Name: NameFull: Husain A – PersonEntity: Name: NameFull: Stefanos N – PersonEntity: Name: NameFull: Barrett P – PersonEntity: Name: NameFull: Jones C – PersonEntity: Name: NameFull: Ness T – PersonEntity: Name: NameFull: Long A – PersonEntity: Name: NameFull: Horswell S – PersonEntity: Name: NameFull: Bosomworth H – PersonEntity: Name: NameFull: Lowenstein J – PersonEntity: Name: NameFull: Richardson G – PersonEntity: Name: NameFull: Swan D – PersonEntity: Name: NameFull: McConnell A – PersonEntity: Name: NameFull: Rose A – PersonEntity: Name: NameFull: Andrew T – PersonEntity: Name: NameFull: Reynolds N – PersonEntity: Name: NameFull: Malvehy J – PersonEntity: Name: NameFull: Carrera C – PersonEntity: Name: NameFull: Alos L – PersonEntity: Name: NameFull: Mailer S – PersonEntity: Name: NameFull: Helm T – PersonEntity: Name: NameFull: Ding L – PersonEntity: Name: NameFull: Bogner P – PersonEntity: Name: NameFull: Podlipnik S – PersonEntity: Name: NameFull: Puig S – PersonEntity: Name: NameFull: McArthur GA – PersonEntity: Name: NameFull: Paragh G – PersonEntity: Name: NameFull: Labus M – PersonEntity: Name: NameFull: Sloan P – PersonEntity: Name: NameFull: Armstrong JL – PersonEntity: Name: NameFull: Lovat PE IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 03 Text: 2024 Mar 15 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1365-2133 Numbering: – Type: volume Value: 190 – Type: issue Value: 4 Titles: – TitleFull: The British journal of dermatology Type: main |
| ResultId | 1 |